Singular Genomics Systems Inc
Save
50.41M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Instruments & Supplies
Industry
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution.
Similar securities
Based on sector and market capitalization
Report issue